NORTHWEST BIOTHERAPEUTICS INC (NWBO) Operating income 2016–2025
NORTHWEST BIOTHERAPEUTICS INC (NWBO) annual operating income history from SEC filings — each fiscal year as reported.
-$59.9MFY2025 · since FY2016: -$79.3M → -$59.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$59.9M | +9.9% |
| FY2024 | -$66.5M | -19.8% |
| FY2023 | -$55.5M | +17.4% |
| FY2022 | -$67.2M | -27.5% |
| FY2021 | -$52.7M | +39.1% |
| FY2020 | -$86.6M | -209.5% |
| FY2019 | -$28.0M | +32.5% |
| FY2018 | -$41.5M | +24.1% |
| FY2017 | -$54.7M | +31.0% |
| FY2016 | -$79.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NWBO financial trends
NWBO RevenueNWBO Net incomeNWBO Net marginNWBO Gross profitNWBO Gross marginNWBO Operating marginNWBO Operating cash flowNWBO Free cash flowNWBO Capital expendituresNWBO Return on equityNWBO Stock buybacksNWBO Dividends paidNWBO Total assetsNWBO Total liabilitiesNWBO Shareholders’ equityNWBO overview →